IPOs

Adlai Nortye IPO gives old Novartis cancer drug new life
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Adlai Nortye
IPOs
Novartis
AN2025
head and neck cancer
solid tumors
Flag link:
Neumora Therapeutics stock surges as Amgen confirmed as major shareholder
Neumora Therapeutics stock surges as Amgen confirmed as major shareholder
Proactive Investors
Amgen
Neumora
IPOs
Flag link:
Emcure Pharma plans to launch $400-500 million IPO in 2024
Emcure Pharma plans to launch $400-500 million IPO in 2024
Mint
Emcure Pharmaceuticals
IPOs
Flag link:
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Antibody biotech Abpro taps SPAC to get back on Nasdaq track 5 years after axed IPO
Fierce Biotech
AbPro
IPOs
SPAC
NASDAQ
Flag link:
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
Flag link:
RayzeBio, Neumora price some of biotech’s largest IPOs this year
RayzeBio, Neumora price some of biotech’s largest IPOs this year
BioPharma Dive
IPOs
RayzeBio
Neumora Therapeutics
Flag link:
SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 mln in US IPO
SoftBank-backed Neumora Therapeutics aims to raise up to $264.8 mln in US IPO
NASDAQ
Neumora Therapeuticsl
funding
Japan
SoftBank
IPOs
Flag link:
Neumora, a richly funded brain drug developer, readies for an IPO
Neumora, a richly funded brain drug developer, readies for an IPO
BioPharma Dive
Neumora Therapeutics
IPOs
depression
navacaprant
Flag link:
RayzeBio plans IPO to push radiotherapy 'pipeline-in-a-product' through phase 3
RayzeBio plans IPO to push radiotherapy 'pipeline-in-a-product' through phase 3
Fierce Biotech
Rayze Bio
radiotherapy
IPOs
Flag link:
In a year with few biotech IPOs, ‘crossover’ financings are hard to find
In a year with few biotech IPOs, ‘crossover’ financings are hard to find
BioPharma Dive
CG Oncology
cancer
IPOs
funding
crossover financing
Flag link:
Fresh off its IPO, Sagimet adds two former Cognoa execs to corner office
Fresh off its IPO, Sagimet adds two former Cognoa execs to corner office
Medical Marketing and Media
Sagimet Biosciences
IPOs
compliance
Flag link:
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
Cell therapy startup Turnstone adds to biotech IPO flurry with $80M raise
BioPharma Dive
IPOs
Turnstone Biologics
cell therapy
Flag link:
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Apogee, Sagimet overshoot IPO expectation as both biotechs land on Nasdaq
Fierce Biotech
NASDAQ
IPOs
Apogee Therapeutics
Sagimet Biosciences
Flag link:
7 Life Science IPOs in 2023
7 Life Science IPOs in 2023
BioSpace
IPOs
Intensity Therapeutics
Acelyrin
CytoMed Therapeutics
Mineralys Therapeutics
Structure Therapeutics
Genelux
Cadrenal Therapeutics
Flag link:
Biophama's flotation haul creeps higher
Biophama's flotation haul creeps higher
EP Vantage
IPOs
biotech
Acelyrin
Apogee Therapeutics
Azitra
CytoMed Therapeutics
Intensity Therapeutics
Mineralys Therapeutics
Paragon Therapeutics
Sagimet Biosciences
Structure Therapeutics
Turnstone Biologics
Flag link:
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Intensity Therapeutics Prices Upsized 3.9M Share IPO at $5/sh
Investing.com
Intensity Therapeutics
oncology
cancer
IPOs
Flag link:
Apogee Files for IPO with Promising Preclinical Immuno Asset
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Flag link:
Turnstone Biologics Files for $86M IPO Amid Financial Difficulties
Turnstone Biologics Files for $86M IPO Amid Financial Difficulties
BioSpace
Turnstone Biologics
IPOs
NASDAQ
Flag link:
Biotech IPOs in 2023: Shaping the Future of Innovation
Biotech IPOs in 2023: Shaping the Future of Innovation
Xtalks
biotech
IPOs
Flag link:
So you think you can go public? Few biotechs dance with Wall Street
So you think you can go public? Few biotechs dance with Wall Street
Fierce Biotech
biotech
IPOs
Structure Therapeutics
Mineralys Therapeutics
Coya Therapeutics
Flag link:

Pages